Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase-Reference-Cited by-同舟云学术

Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase

Published:2004-09 Issue:9 Volume:10 Page:857-860
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Fritsche T.R.,Moet G.J.,Jones R.N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference9 articles.

1. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents;Gilglione;Mol Microbiol,2000

2. Peptide deformylase as an antimicrobial drug target: target validation and resistance development;Apfel;Antimicrob Agents Chemother,2001

3. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor;Clements;Antimicrob Agents Chemother,2001

4. In vitro activities of peptide deformylase inhibitors against Gram-positive pathogens;Wise;Antimicrob Agents Chemother,2002

5. Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor;Jones;J Antimicrob Chemother,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor Combination;Antimicrobial Agents and Chemotherapy;2015-05-26

2. Effect of polymorphism in egg white lysozyme on muramidase and antibacterial activities as well as hatchability in the Japanese quail (Coturnix japonica);Journal of Animal Science;2012-06-01

3. Pharmacokinetics and Unexpected Safety Issues of LBM415, a Novel Oral Peptide Deformylase Inhibitor;Clinical Pharmacology & Therapeutics;2011-06-29

4. Activity of LBM415 Compared to Those of 11 Other Agents against Haemophilus Species;Antimicrobial Agents and Chemotherapy;2006-07

5. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003–2004);Journal of Antimicrobial Chemotherapy;2006-03-20